Morgan Stanley Bridge Bio Pharma, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Morgan Stanley holds 1,375,742 shares of BBIO stock, worth $38.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,375,742

Previous 1,429,009 3.73%

Holding current value

$38.2 Million

Previous $36.2 Million 3.23%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$23.91 - $31.3 $1.27 Million - $1.67 Million	-53,267 Reduced 3.73%	1,375,742 $35 Million
Q2 2024 Oct 17, 2024	BUY	$23.0 - $31.04 $5.68 Million - $7.67 Million	247,115 Added 20.91%	1,429,009 $36.2 Million
Q2 2024 Aug 14, 2024	BUY	$23.0 - $31.04 $5.68 Million - $7.67 Million	247,115 Added 20.91%	1,429,009 $36.2 Million
Q1 2024 Oct 17, 2024	SELL	$27.35 - $40.45 $6.76 Million - $10 Million	-247,115 Reduced 17.29%	1,181,894 $36.5 Million
Q1 2024 Aug 16, 2024	SELL	$27.35 - $40.45 $13.1 Million - $19.3 Million	-477,888 Reduced 28.79%	1,181,894 $36.5 Million
Q1 2024 May 15, 2024	SELL	$27.35 - $40.45 $13.1 Million - $19.3 Million	-477,888 Reduced 28.79%	1,181,894 $36.5 Million
Q4 2023 Aug 16, 2024	BUY	$24.02 - $43.89 $5.54 Million - $10.1 Million	230,773 Added 16.15%	1,659,782 $67 Million
Q4 2023 Feb 13, 2024	BUY	$24.02 - $43.89 $5.09 Million - $9.29 Million	211,722 Added 14.62%	1,659,782 $67 Million
Q3 2023 Nov 15, 2023	BUY	$16.89 - $35.01 $15.1 Million - $31.3 Million	894,647 Added 161.66%	1,448,060 $38.2 Million
Q2 2023 Aug 14, 2023	SELL	$13.29 - $18.01 $4.8 Million - $6.51 Million	-361,378 Reduced 39.5%	553,413 $9.52 Million
Q1 2023 May 15, 2023	SELL	$7.17 - $18.55 $1.01 Million - $2.62 Million	-141,046 Reduced 13.36%	914,791 $15.2 Million
Q4 2022 Feb 14, 2023	BUY	$6.74 - $11.52 $215,835 - $368,904	32,023 Added 3.13%	1,055,837 $8.05 Million
Q3 2022 Nov 14, 2022	SELL	$7.94 - $12.36 $2.47 Million - $3.84 Million	-310,646 Reduced 23.28%	1,023,814 $10.2 Million
Q2 2022 Oct 27, 2022	BUY	$5.21 - $12.14 $924,889 - $2.16 Million	177,522 Added 15.34%	1,334,460 $12.1 Million
Q2 2022 Aug 15, 2022	BUY	$5.21 - $12.14 $924,889 - $2.16 Million	177,522 Added 15.34%	1,334,460 $12.1 Million
Q1 2022 Oct 27, 2022	SELL	$7.34 - $17.16 $1.3 Million - $3.05 Million	-177,522 Reduced 13.3%	1,156,938 $11.7 Million
Q1 2022 May 13, 2022	BUY	$7.34 - $17.16 $5.6 Million - $13.1 Million	762,451 Added 193.28%	1,156,938 $11.7 Million
Q4 2021 Feb 14, 2022	BUY	$11.38 - $53.41 $1.99 Million - $9.35 Million	174,978 Added 79.71%	394,487 $6.58 Million
Q3 2021 Nov 15, 2021	BUY	$46.87 - $64.24 $10.3 Million - $14.1 Million	219,509 New	219,509 $10.3 Million

Others Institutions Holding BBIO

# of Institutions

290

Shares Held

170M

Call Options Held

10.4M

Put Options Held

2.37M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $4.12B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account